Literature DB >> 24268772

Bile acids activate YAP to promote liver carcinogenesis.

Sayeepriyadarshini Anakk1, Manoj Bhosale2, Valentina A Schmidt3, Randy L Johnson4, Milton J Finegold5, David D Moore6.   

Abstract

Elevated bile acid levels increase hepatocellular carcinoma by unknown mechanisms. Here, we show that mice with a severe defect in bile acid homeostasis due to the loss of the nuclear receptors FXR and SHP have enlarged livers, progenitor cell proliferation, and Yes-associated protein (YAP) activation and develop spontaneous liver tumorigenesis. This phenotype mirrors mice with loss of hippo kinases or overexpression of their downstream target, YAP. Bile acids act as upstream regulators of YAP via a pathway dependent on the induction of the scaffold protein IQGAP1. Patients with diverse biliary dysfunctions exhibit enhanced IQGAP1 and nuclear YAP expression. Our findings reveal an unexpected mechanism for bile acid regulation of liver growth and tumorigenesis via the Hippo pathway.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24268772      PMCID: PMC3961013          DOI: 10.1016/j.celrep.2013.10.030

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  60 in total

Review 1.  Preparation of isolated rat liver cells.

Authors:  P O Seglen
Journal:  Methods Cell Biol       Date:  1976       Impact factor: 1.441

2.  Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats.

Authors:  A K Kurz; D Graf; M Schmitt; S Vom Dahl; D Häussinger
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

3.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

Authors:  B Goodwin; S A Jones; R R Price; M A Watson; D D McKee; L B Moore; C Galardi; J G Wilson; M C Lewis; M E Roth; P R Maloney; T M Willson; S A Kliewer
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

4.  Positive influence of dietary deoxycholic acid on development of pre-neoplastic lesions initiated by N-methyl-N-nitrosourea in rat liver.

Authors:  H Tsuda; M Asamoto; M Kagawa; S Uwagawa; K Inoue; M Inui; N Ito
Journal:  Carcinogenesis       Date:  1988-06       Impact factor: 4.944

5.  Resistance of SHP-null mice to bile acid-induced liver damage.

Authors:  Li Wang; Yunqing Han; Chang-Soo Kim; Yoon-Kwang Lee; David D Moore
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

Review 6.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Andrew Burroughs; Jordi Bruix
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

Review 7.  The enzymes, regulation, and genetics of bile acid synthesis.

Authors:  David W Russell
Journal:  Annu Rev Biochem       Date:  2003-01-16       Impact factor: 23.643

8.  Serum bile acids in primary biliary cirrhosis.

Authors:  G M Murphy; A Ross; B H Billing
Journal:  Gut       Date:  1972-03       Impact factor: 23.059

9.  Enhanced preneoplastic liver lesion development under 'selection pressure' conditions after administration of deoxycholic or lithocholic acid in the initiation phase in rats.

Authors:  S Kitazawa; A Denda; M Tsutsumi; T Tsujiuchi; K Hasegawa; K Tamura; H Maruyama; Y Konishi
Journal:  Carcinogenesis       Date:  1990-08       Impact factor: 4.944

10.  Serum bile acids in liver disease.

Authors:  G Neale; B Lewis; V Weaver; D Panveliwalla
Journal:  Gut       Date:  1971-02       Impact factor: 23.059

View more
  63 in total

1.  Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.

Authors:  A Wree; C D Johnson; J Font-Burgada; A Eguchi; D Povero; M Karin; A E Feldstein
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

2.  Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers.

Authors:  Willscott E Naugler; Branden D Tarlow; Lev M Fedorov; Matthew Taylor; Carl Pelz; Bin Li; Jennifer Darnell; Markus Grompe
Journal:  Gastroenterology       Date:  2015-05-29       Impact factor: 22.682

Review 3.  Therapeutic pipeline in nonalcoholic steatohepatitis.

Authors:  Raj Vuppalanchi; Mazen Noureddin; Naim Alkhouri; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-10       Impact factor: 46.802

4.  TAZ Is a Negative Regulator of PPARγ Activity in Adipocytes and TAZ Deletion Improves Insulin Sensitivity and Glucose Tolerance.

Authors:  Dalila El Ouarrat; Roi Isaac; Yun Sok Lee; Da Young Oh; Joshua Wollam; Denise Lackey; Matthew Riopel; Gautam Bandyopadhyay; Jong Bae Seo; Revathy Sampath-Kumar; Jerrold M Olefsky
Journal:  Cell Metab       Date:  2019-11-07       Impact factor: 27.287

5.  Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15/19 signaling to repress bile acid synthesis.

Authors:  Shuangwei Li; Diane D F Hsu; Bing Li; Xiaolin Luo; Nazilla Alderson; Liping Qiao; Lina Ma; Helen H Zhu; Zhao He; Kelly Suino-Powell; Kaihong Ji; Jiefu Li; Jianhua Shao; H Eric Xu; Tiangang Li; Gen-Sheng Feng
Journal:  Cell Metab       Date:  2014-06-26       Impact factor: 27.287

6.  Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.

Authors:  Guoxiang Xie; Xiaoning Wang; Fengjie Huang; Aihua Zhao; Wenlian Chen; Jingyu Yan; Yunjing Zhang; Sha Lei; Kun Ge; Xiaojiao Zheng; Jiajian Liu; Mingming Su; Ping Liu; Wei Jia
Journal:  Int J Cancer       Date:  2016-06-17       Impact factor: 7.396

Review 7.  Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.

Authors:  Sachin H Patel; Fernando D Camargo; Dean Yimlamai
Journal:  Gastroenterology       Date:  2016-12-19       Impact factor: 22.682

8.  IQGAP1 Binds to Yes-associated Protein (YAP) and Modulates Its Transcriptional Activity.

Authors:  Samar Sayedyahossein; Zhigang Li; Andrew C Hedman; Chase J Morgan; David B Sacks
Journal:  J Biol Chem       Date:  2016-07-20       Impact factor: 5.157

9.  Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans.

Authors:  Shanshan Zhang; Jingxiao Wang; Haichuan Wang; Lingling Fan; Biao Fan; Billy Zeng; Junyan Tao; Xiaolei Li; Li Che; Antonio Cigliano; Silvia Ribback; Frank Dombrowski; Bin Chen; Wenming Cong; Lixin Wei; Diego F Calvisi; Xin Chen
Journal:  Am J Pathol       Date:  2018-01-31       Impact factor: 4.307

Review 10.  Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer.

Authors:  Dean Yimlamai; Brendan H Fowl; Fernando D Camargo
Journal:  J Hepatol       Date:  2015-07-28       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.